Asian Annals Click here to go to Maquet website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Shunji Sano
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sano, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sano, S.
Asian Cardiovasc Thorac Ann 2007;15:83-85
© 2007 Asia Publishing EXchange Ltd


EDITORIAL

New Era in Management of Hypoplastic Left Heart Syndrome

Shunji Sano, MD

Japan

The first 20% of the full text of this article appears below.

Hypoplastic left heart syndrome (HLHS) represents an anatomical spectrum of congenital hearts defects with varying degrees of underdevelopment of the left-sided heart structures.1 Before 1980, the condition was practically always fatal, usually in the first month of life.2 Since Norwood and colleagues3 reported successful surgical palliation (the Norwood procedure) in 1981, and multistaged reconstructive surgery involving the Norwood procedure (stage I) followed by bidirectional Glenn (stage II) or hemi-Fontan (stage II) and Fontan operations (stage III), the outlook for patients with HLHS has dramatically improved. The Norwood procedure must provide unobstructed systemic blood flow from the right ventricle (RV), relief of obstruction to pulmonary venous return, sufficient blood flow to the lungs in the absence of significant volume overload, and sufficient coronary circulation. Balancing pulmonary and systemic flows is critical to success. Despite successful reconstructive surgery, most deaths occur in the first 24 to 48 h postoperatively due to hemodynamic instability secondary to the unpredictable rapid fall in pulmonary vascular resistance.4 Maldistribution of cardiac output associated with the systemic-to-pulmonary shunt has been implicated as a major cause of early death after stage I palliation.5,6 A review of 122 postmortem cases after the Norwood procedure at the Children’s Hospital, Boston, indicated that the most prevalent causes of death were impairment of coronary perfusion, excessive pulmonary blood flow, and obstruction to pulmonary blood flow.7 This maldistribution of blood flow was implicated in more than 60% of postoperative deaths.

Therefore, over the last decade, . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by the Asia Publishing EXchange Ltd.